BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16531169)

  • 1. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants.
    Taneepanichskul S; Reinprayoon D; Thaithumyanon P; Praisuwanna P; Tosukhowong P; Dieben T
    Contraception; 2006 Apr; 73(4):368-71. PubMed ID: 16531169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device.
    Reinprayoon D; Taneepanichskul S; Bunyavejchevin S; Thaithumyanon P; Punnahitananda S; Tosukhowong P; Machielsen C; van Beek A
    Contraception; 2000 Nov; 62(5):239-46. PubMed ID: 11172794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.
    Brito MB; Ferriani RA; Quintana SM; Yazlle ME; Silva de Sá MF; Vieira CS
    Contraception; 2009 Dec; 80(6):519-26. PubMed ID: 19913145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.
    Graesslin O; Korver T
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():4-12. PubMed ID: 18330813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth.
    Bahamondes L; Bahamondes MV; Modesto W; Tilley IB; Magalhães A; Pinto e Silva JL; Amaral E; Mishell DR
    Fertil Steril; 2013 Aug; 100(2):445-50. PubMed ID: 23623474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive efficacy and side effects of Implanon.
    Gezginc K; Balci O; Karatayli R; Colakoglu MC
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):362-5. PubMed ID: 17853166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
    Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A; Biswas S; Viegas OA
    Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: a comparative study.
    Oderich CL; Wender MC; Lubianca JN; Santos LM; de Mello GC
    Contraception; 2012 Feb; 85(2):173-6. PubMed ID: 22067787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
    Yao XY; Du MK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):419-22. PubMed ID: 12921554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
    Croxatto HB
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Exluton (progestogen-only OC) and the Multiload Cu 250 IUD on lactation.
    Delgado Betancourt J; Sandoval JC; Sanchez F; Vallesteros De Cano P; De La Luz Bantista M; Jimenez F
    Contracept Deliv Syst; 1984 Apr; 5(2):91-5. PubMed ID: 12266200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the effects of a progestogen-only pill containing desogestrel and an intrauterine contraceptive device in lactating women.
    Bjarnadóttir RI; Gottfredsdóttir H; Sigurdardóttir K; Geirsson RT; Dieben TO
    BJOG; 2001 Nov; 108(11):1174-80. PubMed ID: 11762658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.